| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/2004 | EP1461032A2 Use of tyrosine kinase inhibitors for promoting hair growth |
| 09/29/2004 | EP1461031A2 Formulations for oral administration of cromolyn sodium |
| 09/29/2004 | EP1461030A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 09/29/2004 | EP1461029A1 Taxane based compositions and methods of use |
| 09/29/2004 | EP1461028A2 Treatment for age-related macular degeneration |
| 09/29/2004 | EP1461027A1 Treatment of neoplasia |
| 09/29/2004 | EP1461026A2 Method for treating ocular hypertension |
| 09/29/2004 | EP1461025A1 Treatment of neurodegenerative and cardiovascular disorders |
| 09/29/2004 | EP1461024A1 Treatment of wounds and compositions employed |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1461022A2 Use of selective pde5 inhibitors for treating partial and global respiratory failure |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1461019A2 Bioadhesive drug delivery system with enhanced gastric retention |
| 09/29/2004 | EP1461018A2 Dual controlled release dosage form |
| 09/29/2004 | EP1461017A1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic |
| 09/29/2004 | EP1461015A2 Compositions containing both sedative and non-sedative antihistamines |
| 09/29/2004 | EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/29/2004 | EP1461013A2 Method of producing a nicotine composition |
| 09/29/2004 | EP1461010A2 Hydroxamic acid and its derivatives as inhibitors of melanocyte tyrosinase for topical skin lighteners |
| 09/29/2004 | EP1461004A1 Dialkyl-substituted acetic acid and glyceric acid based active substance combinations against bacteria, mycota and viruses |
| 09/29/2004 | EP1460999A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 09/29/2004 | EP1460998A2 Extended release pharmaceutical tablet of metformin |
| 09/29/2004 | EP1460996A2 Novel-n-4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa |
| 09/29/2004 | EP1460995A1 Transdermal transport of compounds |
| 09/29/2004 | EP1460992A2 Stabilized reverse micelle compositions and uses thereof |
| 09/29/2004 | EP1460969A2 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 09/29/2004 | EP1460964A2 Oral immunostimulation of mammals, birds, fish and reptiles from (1-4) linked b -d-mannuronic acid |
| 09/29/2004 | EP1419171A4 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 09/29/2004 | EP1392700B1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 09/29/2004 | EP1390364B1 Aryl-8-azabicyclo 3.2.1]octanes for the treatment of depression |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1372633B1 Irrigating fluid comprising nitrous oxide |
| 09/29/2004 | EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/29/2004 | EP1332246B1 Process for preparing low defect density silicon using high growth rates |
| 09/29/2004 | EP1307436B1 Process for the preparation of baccatin iii derivatives |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1299350B1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 09/29/2004 | EP1292288B1 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 09/29/2004 | EP1289495B1 Process for the preparation of a sterile ointment containing acyclovir |
| 09/29/2004 | EP1287001B1 Thiophene derivatives useful as anticancer agents |
| 09/29/2004 | EP1282394B1 Use of n,n'-dibenzyl ethylene diamine n,n'-diacetic acid derivatives as anti-pollution agent |
| 09/29/2004 | EP1272180B1 Concentrated solutions of carvedilol |
| 09/29/2004 | EP1239882B1 Formulations of adenosine a1 agonists and 5ht3 agonists |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1192162B1 Taxane derivatives and processes for the preparation thereof |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1178807B1 Use of org 33245 in combined intermittent hormone therapy and contraception |
| 09/29/2004 | EP1176960B1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 09/29/2004 | EP1169339B1 Macrocyclic peptides inhibiting the hepatitis c virus ns3 protease |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1144412B1 Immunosuppressive effects of pteridine derivatives |
| 09/29/2004 | EP1124563B1 Methods and compositions for the prevention of tolerance to bronchodilators |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 09/29/2004 | EP1100483B1 Glucocorticoid-selective anti-inflammatory agents |
| 09/29/2004 | EP1090019B1 Adenosine derivatives |
| 09/29/2004 | EP1090018B1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 09/29/2004 | EP1083879B1 Devices for providing prolonged drug therapy |
| 09/29/2004 | EP1071418B1 New treatments for nervous disorders |
| 09/29/2004 | EP1067965B1 Pharmaceutical composition for treating cerebral apoplexy and craniocerebral trauma |
| 09/29/2004 | EP1062201B1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/29/2004 | EP1059915B1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1037531B1 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | EP1019378B1 Hypoglycemic and hypolipidemic compounds |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1012140B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/29/2004 | EP1003526B1 Covalently linked n,o-carboxymethylchitosan and uses thereof |
| 09/29/2004 | EP1003503B1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 09/29/2004 | EP1001790B1 Compositions for lubricating and separating tissues and biological membranes |
| 09/29/2004 | EP1000059B1 Tricyclic vasopressin agonists |
| 09/29/2004 | EP0999832B1 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | EP0989848B1 Film-coated tablet for improved upper gastrointestinal tract safety |
| 09/29/2004 | EP0969813B1 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| 09/29/2004 | EP0946184B1 Novel formulations for the transdermal administration of fluoxetine acetate and fluoxetine maleate |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0914146B1 Morphogen treatment for chronic renal failure |
| 09/29/2004 | EP0912533B1 Alkylaminobenzothiazole and -benzoxazole derivatives |
| 09/29/2004 | EP0912196B1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 09/29/2004 | EP0820456B1 1,2,4-triazolo 4,3-b]pyridazine derivatives and their use |
| 09/29/2004 | EP0815857B1 Antiobestic agent containing procyanidin as the active ingredient |
| 09/29/2004 | EP0797451B1 Compositions containing arabinogalactan and polyphenols from larix for treating gastrointestinal disorders |
| 09/29/2004 | EP0781134B9 Scopolamine plaster |
| 09/29/2004 | EP0736016B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor |
| 09/29/2004 | EP0713702B1 Anxiolytic agent |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | CN1533442A Cimeric immunomodulatory compounds and methods of using the same |
| 09/29/2004 | CN1533400A Probes, system and methods for drug discovery |
| 09/29/2004 | CN1533397A 6-2'-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral acticity |